EUVIMEDEUVIMED entdecken
Crossref

Evaluation of the Level of Immune Checkpoint Programmed Death Protein 1 (PD-1) in Toxoplasmosis

Ruqayah A. Abdul Ameer, Huda D. Al-Marsomy

Iraqi Journal of Medical Sciences · 01.06.2026 · 24 (1) · 17-22

DOI: 10.22578/kmsx8v20 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Iraqi Journal of Medical Sciences, online erschienen am 01.06.2026. Verfasst von Ruqayah A. Abdul Ameer und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Toxoplasma gondii (T. gondii) is known to manipulate host immune responses to establish a persistent infection. This manipulation involves modulation of immune regulatory pathways, including those mediated by checkpoint molecules like programmed cell death protein 1 (PD-1). The parasite employs various strategies to evade host immune surveillance and promote its survival within the host organism.

Objective

This study aimed to determine of the levels of PD-1 during acute T. gondii infection by enzyme linked immunosorbent assay (ELISA).

Methods

In this case control study, samples were collected from 350 women suspected Tox with an age range from (18-48) years. According to the presence of anti-T. gondii (IgM) in serum of women using ELISA technique, the women were divided into 2 groups, group 1 with positive IgM, and group 2 with negative IgM. Serum levels PD-1 were measured in both groups.

Results

The results showed a significant higher level serological biomarker (PD-1) in T. gondii IgM patients than in controls (p value 0.0001). Also, there was a significant variation of PD-1 level according to clinical history (p value 0.004), highest in those with delayed pregnancy, and lowest in those with cervical lymphadenopathy.

Conclusion

There is a significant higher level serological biomarker (PD-1) in T. gondii IgM patients than in controls. Also, there is a significant variation of PD-1 level according to clinical history Keywords:Toxoplasmosis, IgM, PD-1.

Zitieren

APA

Ameer, R. A. A., & Al-Marsomy, H. D. (2026). Evaluation of the Level of Immune Checkpoint Programmed Death Protein 1 (PD-1) in Toxoplasmosis. Iraqi Journal of Medical Sciences, 24(1), 17-22. https://doi.org/10.22578/kmsx8v20

Vancouver

Ameer RAA, Al-Marsomy HD. Evaluation of the Level of Immune Checkpoint Programmed Death Protein 1 (PD-1) in Toxoplasmosis. Iraqi Journal of Medical Sciences. 2026;24(1):17-22. doi:10.22578/kmsx8v20

BibTeX
@article{Ameer2026,
  author = {Ameer, Ruqayah A. Abdul and Al-Marsomy, Huda D.},
  title = {Evaluation of the Level of Immune Checkpoint Programmed Death Protein 1 (PD-1) in Toxoplasmosis},
  journal = {Iraqi Journal of Medical Sciences},
  year = {2026},
  volume = {24},
  number = {1},
  pages = {17--22},
  doi = {10.22578/kmsx8v20}
}
Kostenlos starten →